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Somatic cells can be reprogrammed to an ES-like state to
create induced pluripotent stem cells (iPSCs) by ectopic
expression of four transcription factors, Oct4, Sox2, Klf4
and cMyc. Here, we show that cellular microRNAs
(miRNAs) regulate iPSC generation. Knock-down of
key microRNA pathway proteins resulted in signiﬁcant
decreases in reprogramming efﬁciency. Three miRNA
clusters, miR-17B92, miR-106bB25 and miR-106aB363,
were shown to be highly induced during early reprogram-
ming stages. Several miRNAs, including miR-93 and miR-
106b, which have very similar seed regions, greatly
enhanced iPSC induction and modulated mesenchymal-
to-epithelial transition step in the initiation stage of repro-
gramming, and inhibiting these miRNAs signiﬁcantly
decreased reprogramming efﬁciency. Moreover, miR-iPSC
clones reached the fully reprogrammed state. Further
analysis revealed that Tgfbr2 and p21 are directly targeted
by these miRNAs and that siRNA knock-down of both genes
indeed enhanced iPSC induction. Here, for the ﬁrst time, we
demonstrate that miR-93 and its family members directly
target TGF-b receptor II to enhance iPSC generation. Overall,
we demonstrate that miRNAs function in the reprogram-
ming process and that iPSC induction efﬁciency can be
greatly enhanced by modulating miRNA levels in cells.
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Introduction
Induced pluripotent stem cells (iPSCs), which exhibit proper-
ties similar to embryonic stem (ES) cells, were originally
generated by ectopic expression of four transcription factors,
Oct4, Sox2, Klf4 and cMyc, in mouse somatic cells (Takahashi
and Yamanaka, 2006). In human and mouse somatic cells,
besides these factors (Takahashi et al, 2007; Lowry et al,
2008; Park et al, 2008), iPSCs can be generated with an
alternative set of four factors, namely Oct4, Nanog, Lin28
and Sox2 (Yu et al, 2007). Although cell types from several
different tissues are conﬁrmed to be reprogrammable
(Meissner et al, 2007; Aoi et al, 2008; Eminli et al, 2008;
Hanna et al, 2008; Giorgetti et al, 2009), a major bottleneck in
iPSC derivation and therapeutic use is low reprogramming
efﬁciency, typically from 0.01 to 0.2% (Takahashi and
Yamanaka, 2006; Meissner et al, 2007; Aoi et al, 2008;
Nakagawa et al, 2008). Although tremendous effort has
been focused on screening for small molecules to enhance
reprogramming efﬁciency and on developing new methods
for iPSC derivation (Shi et al, 2008a,b; Ichida et al, 2009;
Lyssiotis et al, 2009; Maherali and Hochedlinger, 2009; Li
et al, 2009b), mechanisms underlying reprogramming of
primary ﬁbroblasts to an ES cell-like state are still largely
unknown.
Several elegant approaches have been employed to im-
prove reprogramming efﬁciency. Small molecule-based meth-
ods have been developed based on observation that
treatment of cells with DNA methyltransferase 1 (Dnmt1)
inhibitors accelerates reprogramming (Mikkelsen et al, 2008).
TGF-b inhibition also enables more efﬁcient iPSC induction,
as does omission of Sox2 and cMyc (Ichida et al, 2009;
Maherali and Hochedlinger, 2009). In addition, array analysis
shows that partially reprogrammed iPSCs can be created and
then pushed to become fully reprogrammed following treat-
ment with factors such as methyl transferase inhibitors
(Mikkelsen et al, 2008). Genome-wide analysis of promoter
binding and induction of gene expression by the four repro-
gramming factors demonstrates that they bind to similar
targets in iPS and mES cells and likely regulate similar sets
of genes, and also that targeting of reprogramming factors is
altered in partial iPSCs (Sridharan et al, 2009). More recently,
several groups showed that p53-mediated tumour suppressor
pathways may antagonize iPSC induction (Banito et al, 2009;
Hong et al, 2009; Kawamura et al, 2009; Utikal et al, 2009; Li
et al, 2009a). Both p53 and its downstream effector p21 are
induced during reprogramming, and minimizing expression
of both enhances iPSC colony formation. As these proteins
are upregulated in most cells expressing the four reprogram-
ming factors, and cMyc reportedly blocks p21 expression
(Gartel et al, 2001; Seoane et al, 2002), it is unclear how
ectopic expression of these four factors overcomes the cellu-
lar responses to oncogenes/transgenes overexpression and
why only a very small population of cells becomes fully
reprogrammed.
microRNAs (miRNAs) are 18–24 nucleotide single-
stranded RNAs associated with a protein complex called the
RNA-induced silencing complex. Small RNAs are usually
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823generated from non-coding regions of gene transcripts and
function to suppress gene expression by translational repres-
sion (Ambros, 2004; Bartel, 2004; Rana, 2007; Kim et al,
2009a). In recent years, miRNAs have been found to function
in many important processes, such as expression of self-
renewal genes in human ES (hES) cells (Xu et al, 2009),
cell cycle control of ES cells (Wang et al, 2008), alternative
splicing (Makeyev et al, 2007) and heart development
(Latronico and Condorelli, 2009). Furthermore, it was
recently reported that ES cell-speciﬁc miRNAs enhanced
mouse iPSC derivation and replaced the function of cMyc
during reprogramming (Judson et al, 2009) and hES-speciﬁc
miR-302 could alleviate the senescence response due to four
factor expression in human ﬁbroblast (Banito et al, 2009).
However, since these miRNAs are not highly expressed until
very late stages of reprogramming, whether miRNAs mediat-
ing regulation of gene expression have an important role in
iPSC induction remains unknown.
Here, we show that miRNAs function directly in iPSC
induction and that interference with the miRNA biogenesis
machinery signiﬁcantly decreases reprogramming efﬁciency.
We also identiﬁed three clusters of miRNAs, miR-17B92,
miR-106bB25 and miR-106aB363, which are highly induced
during early stages of reprogramming. Functional analysis
demonstrated that introducing these miRNAs into MEFs
enhanced Oct4-GFPþ iPSC colony formation. We also
found that Tgfbr2 and p21, both of which inhibit reprogram-
ming, are directly targeted by these miRNAs and that block-
ing their activity signiﬁcantly decreased reprogramming
efﬁciency. Overall, we propose that miR-93 and miR-106b
are key regulators of reprogramming activity.
Results
Post-transcriptional regulation functions in
reprogramming of MEFs to iPSCs
To investigate the role of post-transcriptional gene regulation
in iPSC induction, we used lentiviral shRNA vectors targeting
mouse Ago2 as well as Dicer and Drosha to stably knock
down these factors in primary Oct4-GFP MEFs. Knock-down
efﬁciency of shRNA constructs was veriﬁed by both western
analysis and RT–qPCR (Figure 1A; Supplementary Figure S1a
B A
CD
0.5
1.0
1.5
Mock
pLKO
pGIPZ
shAgo2
0.0
R
e
l
a
t
i
v
e
 
m
R
N
A
 
l
e
v
e
l
Mock
pLKO
pGIPZ
shAgo2
pLKO pGIPZ
mActin
P=0.003357 P=0.00181
1.5 1.5
1.0 1.0
0.5 0.5
0.0 0.0
NonTargeting 
NonTargeting 
pLKO-shAgo2
pLKO-shAgo2
R
e
l
a
t
i
v
e
 
A
P
+
 
c
o
l
o
n
i
e
s
R
e
l
a
t
i
v
e
 
G
F
P
+
 
c
o
l
o
n
i
e
s
mAgo2
4F only shAgo2
Figure 1 The RNAi machinery functions in mouse iPSC induction. (A) Knock-down of mouse RNAi machinery gene Ago2 by shRNAs. MEFs
were transduced with lentiviral shRNAs plus 4mg/ml polybrene, and total RNAs or proteins were harvested at day 3 post-transduction. mRNA
and protein levels of targeted genes were analysed by RT–qPCR and western blotting, respectively. pLKO is the empty vector control for the
shRNA lentiviral vectors. pGIPZ is a lentiviral vector expressing a non-targeting shRNA. (B) Knock-down of Ago2 dramatically decreases iPS
induction by 4F. Primary MEFs were transduced with the four reprogramming factors (OSKM (4F)) plus shRNA Ago2. Colonies were stained at
day 14 post-transduction for alkaline phosphatase (AP), which is a marker for mES/iPS cells. pLKO and pGIPZ vectors served as negative
controls. (C) Knock-down of Ago2 decreases iPS induction by OSK. Colonies were stained and quantiﬁed for AP at day 21 post-transduction.
Error bar represents s.d. of duplicate wells. (D) GFPþ colony quantiﬁcation of iPSC with shAgo2. GFPþ colonies were quantiﬁed at day 21
post-transduction. Error bar represents s.d. of duplicate wells.
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mRNA level knock-down, as well as signiﬁcant decreases in
protein levels. We then transduced MEFs with each of these
shRNAs separately along with viruses expressing the four
OSKM (Oct4, Sox2, Klf4 and cMyc) factors at a volume ratio
of 1:1:1:1:1. After 14 days, colonies were ﬁxed and stained for
alkaline phosphatase (AP) activity, a widely used ES cell
marker. We found that knock-down of either Dicer, Drosha or
Ago2 resulted in a dramatic decrease in the number of APþ
colonies compared with pLKO and pGIPZ controls (Figure 1B;
Supplementary Figure S1c). We also observed similar results
by using OSK (3F) transduction. Both GFPþ and APþ
colony quantiﬁcation veriﬁed that knocking down Ago2
dramatically decrease reprogramming efﬁciency, while pro-
liferation of transduced ﬁbroblasts were not affected (Figure
1C and D; Supplementary Figure S2).
Despite the decrease in reprogramming efﬁciency upon
Ago2 knock-down, we observed some GFPþ colonies
in shAgo2-infected MEFs and further characterization
determined that these colonies were positive for shRNA
integration and shRNAs were actively expressed
(Supplementary Figure S3a and b). These cells also expressed
all the tested ES-speciﬁc markers and had turned on the
endogenous Oct4 locus as well as low expression of p21
and Tgfbr2 (Supplementary Figure S3c–e). Further studies
to induce differentiation showed that shAgo2 clones had
compromised differentiation capacities as Nanog, one of the
self-renewal genes, could not be silenced as efﬁciently as
observed in control ES cells when treated with retinoid acid
(Supplementary Figure S3f). Understanding the detailed
mechanism of GFPþ colony formation in shAgo2-infected
MEFs needs further investigation. Taken together, these
data strongly suggest that post-transcriptional regulation,
particularly that mediated by miRNAs, functions in the
reprogramming process.
miR-17, miR-25, miR-106a and miR-302b clusters are
induced during the early stage of reprogramming
Expression of the four reprogramming factors induces nu-
merous changes in gene expression during iPS induction
(Mikkelsen et al, 2008; Sridharan et al, 2009). We hypothe-
sized that some ES cell-speciﬁc miRNAs might be induced by
these factors to facilitate reprogramming. Based on pre-
viously published results (Houbaviy et al, 2003; Landgraf
et al, 2007), we analysed nine miRNA clusters highly ex-
pressed in mouse ES (mES) cells (Supplementary Table 1).
Two representative miRNAs from each cluster were evaluated
using a miR qPCR-based method to quantify expression
changes at different reprogramming stages—namely days 0,
4, 8 and 12—following transduction of the OSKM factors.
Many ES cell-speciﬁc miRNAs, such as the miR-290 and miR-
293 clusters, were not induced until day 8 (Supplementary
Figure S4), at which stage GFPþ colonies were already
detectable. Interestingly, we found that several other clusters,
including miR-17B92, miR-106bB25, miR-106aB363 and
miR-302bB367, were expressed to varying extents by day 4
of induction (Figure 2A). Among these four clusters, the level
of miR-302bB367 in MEFs was the lowest (data not shown).
It is noteworthy that of the three clusters highly induced at
reprogramming day 4, many shared very similar seed regions
(Figure 2B). In general, seed region of a miRNA decides the
target speciﬁcity, however, recent reports suggest that other
mechanisms could also have roles in miRNA targeting (Tay
et al, 2008; Lal et al, 2009; Wang et al, 2010). Together, our
ﬁndings suggest that these miRNAs function in reprogram-
ming and could target similar sets of genes.
We next asked which of the four reprogramming factor(s)
induced these miRNAs by transducing MEFs with different
combinations of OSKM factors at the same dose and under-
taking miR qPCR analysis at day 4 post-infection (Figure 2C).
This analysis conﬁrmed that cMyc alone could induce miR-
17B92, miR-106bB25 and miR-106aB363 cluster expres-
sion, as reported previously (Mendell, 2008). However, in
each case, a combination of all four reprogramming factors
induced the most abundant expression of miRNA clusters,
and that robust expression was correlated with the highest
reprogramming efﬁciency (Figure 2C).
miR-93 and miR-106b enhance iPSC induction and
mesenchymal-to-epithelial transition step of
reprogramming
As the four identiﬁed miRNA clusters contain several
miRNAs with similar seed regions, we chose the miR-
106bB25 cluster for further analysis because it contains
only three miRNAs: miR-25, miR-93 and miR-106b. miR-93
and miR-106b have the identical seed regions, and both
were highly induced by the four reprogramming factors
(Figure 2A). Besides, miRNAs mimics could be transfected
into MEFs with high efﬁciency and exhibited a half-life of 4
days (Supplementary Figures S7 and S9b). Thus, we reasoned
that we might observe more efﬁcient iPSC induction if we
ectopically expressed these miRNAs during reprogramming.
To test this hypothesis, we directly transfected miRNA mi-
mics into MEFs harbouring Oct4-GFP at days 0 and 5 with
vectors expressing either all four factors (4F, OSKM) or only
Oct4, Sox2 and Klf4 (OSK) and assayed reprogramming based
on GFP expression (Figure 3A). GFPþ colonies were counted
on day 11 to evaluate reprogramming efﬁciency (Figure 3B).
Transfection of miR-93 and miR-106b mimics promoted a 4–6-
fold increase in the number of GFPþ colonies in both 4F and
OSK transduction (Figure 3C and D; Supplementary Figure
S22, Supplementary Table 3), conﬁrming that these miRNAs,
which are induced during iPSC induction, facilitate MEF
reprogramming. Dose/response analysis showed that
enhanced reprogramming efﬁciency occurred at as low as
the 5–15nM range of miRs (Supplementary Figure S5). To
conﬁrm that the enhancement by these miRNAs was from
induction of bonaﬁde iPS colonies, we further analysed the
expression of another marker Nanog in miR-106b-transfected
cells. In both 4Fand OSK-infected samples, miR-106b transfec-
tion consistently increased the relative Nanog expression
(Supplementary Figure S6a and b). Immunostaining and fol-
lowed by Nanogþ colonies quantiﬁcation further proved that
almost every Oct4-GFPþ colony is also Nanogþ at that stage
(Supplementary Figure S6c) and miR-106b can enhance for-
mation of both colonies (Supplementary Figure S6d and e). AP
staining showed no obvious increase in the number of APþ
colonies in miR mimic transfections (Supplementary Figure
S8a), suggesting that miR-93 and miR-106b facilitate matura-
tion of iPS colonies. This idea was supported by our observa-
tion of the OSK system, in which many GFPþ colonies were
apparent at day 15 post-OSK transduction in miR mimic-
transfected cells, while control wells did not exhibit any
mature iPS colonies at this stage (data not shown).
RNA-based iPSC reprogramming
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iPSC induction, we used miR inhibitors (Hutvagner et al,
2004; Meister et al, 2004; Vermeulen et al, 2007) to knock
down targeted miRNAs during the reprogramming process.
All of the miR inhibitors could efﬁciently decrease target miR
expression and their transfection did not affect proliferation
(Supplementary Figure S9a and c). Consistent with miR
mimic experiments, miR-93 and miR-106b knock-down pro-
moted a dramatic decrease in the number of GFPþ colonies
(Figure 3E). It is also noteworthy that although the miR-25
mimic did not enhance MEF iPS induction, knocking down
this miRNA decreased reprogramming efﬁciency by B40%
(Figure 3E). These results suggest that miR-25 could also
function during reprogramming.
Recent reports have identiﬁed that during the initial
stage of reprogramming, a mesenchymal-to-epithelial transi-
tion (MET) is required (Li et al, 2010; Samavarchi-Tehrani
et al, 2010). E-Cadherin is one of the most important genes for
MET process and we used it as the marker to determine
whether miR-106b could facilitate this step of iPSC genera-
tion. We detected a signiﬁcant increase of E-Cadherin expres-
sion in both 4F and OSK-infected samples (Figure 3F and G).
In addition, knocking down of miR-106b also dramatically
decreased the induction of E-Cadherin expression
(Figure 3H). Overall, these data indicate that miR-93 and
miR-106 promote reprogramming of MEFs to iPSCs
and modulate MET transition in the initiation step of
reprogramming.
A 40
*
* *
*
*
35
30
25
20
6
4
2
0
miR-15b
miR-16
miR-17
miR-19a
miR-25
miR-32
miR-93
miR-106a
miR-106b
miR-130a
miR-290
miR-292
miR-293
miR-294
miR-302b
miR-363
miR-367
R
e
l
a
t
i
v
e
 
m
i
R
 
l
e
v
e
l
C
B
4
3
2
1
0
miR-17
miR-93
miR-106a
miR-106b
R
e
l
a
t
i
v
e
 
m
i
R
 
e
x
p
r
e
s
s
i
o
n
4F OSK OS Oct4 Sox2 Klf4 cMyc MEF
Figure 2 miR-17, miR-25, miR-106a and miR-302b clusters are induced during early stages of reprogramming. (A) Induction of 10 miRNA
clusters in the early stages after transduction with the four reprogramming factors. miR RT–qPCR was used to quantify expression levels of
representative miRNAs from clusters highly expressed in ES cells. Total RNAs from day 0 MEFs and from MEFs transduced with reprogramming
factors at day 4 post-infection were analysed. Blue bars: day 4 MEFs; white bars: day 0 MEFs. Asterisks indicate induced miRNAs. (B) Seed
region comparison of different miR clusters induced at day 4 post-reprogramming factor transduction. Red indicates similar seed regions.
(C) Representative miRNAs can be induced with different combinations of reprogramming factors. miRNA expression was quantiﬁed at 4 days
post-transduction.
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Next, we asked whether induced cells reached a fully
pluripotent state. To answer this question, several iPS clones
for each miRNA as well as miR controls were derived and
analysed for expression of pluripotency markers. All clones
were GFPþ indicative of reactivated Oct4 expression
(Figure 4A). Immunostaining conﬁrmed that Nanog and
SSEA1 were also activated in all clones (Figure 4B). RT–
qPCR for other mES markers such as ERas, ECatI and
endogeneous Oct4 showed similar results (Figure 4C).
Whole genome mRNA expression proﬁling also indicated
that derived clones exhibited a gene expression pattern
more similar to mES cells than MEFs (Supplementary
Figure S10a). Promoter methylation of endogenous Nanog
loci was also analysed, and all tested clones showed de-
methylated promoters, as is observed in mES cells (Blelloch
et al, 2006) (Supplementary Figure S10b).
To investigate whether derived clones exhibit the full
differentiation capacity of mES cells, we evaluated
embryoid body (EB) formation. All derived clones showed
efﬁcient EB formation, and EBs showed positive staining
for lineage markers such as b-tubulin III (ectoderm),
AFP (endoderm) and a-actinin (mesoderm) (Figure 4D).
Beating EBs were also derived from these cells
(Supplementary Video 1), indicating that functional
cardiomyocytes can be derived from these miR-iPSC
clones (Supplementary Videos 2 and 3). When these
miR-iPSCs were injected into athymus nude mice, teratomas
were readily derived in 3–4 weeks (Figure 4E). Finally,
as a more stringent test, we injected miR-derived iPSC
clones into albino/black B6 blastocysts and generated
chimera mice (Figure 4F). Furthermore, these cells could
contribute to the genital ridge of derived E13.5 embryos
(Supplementary Figure S11). Taken together, these results
indicate that the enhancing effects of miR-93 and miR-106b
on reprogramming do not alter differentiation capacity of
induced pluripotent cells and that those derived clones can
differentiate into all three germ lines.
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Figure 3 miR-93 and miR-106b greatly enhance iPS induction. (A) Reprogramming assay timeline. miRNA mimics or inhibitors were
transfected at a ﬁnal concentration of 50nM on days 0 and 5 of reprogramming. GFPþ colonies were quantiﬁed at day 11 for 4F induction
and days 15–20 for OSK induction. (B) Representative images of GFPþ colonies from reprogrammed Oct4-GFP MEFs transfected with miRNA
mimics. Arrows indicate GFPþ colonies. (C) miR-93 and miR-106b mimics enhance iPS induction with 4F induction. Oct4-GFP MEFs were
transfected with 50nM of the indicated miRNAs at days 0 and 5 of reprogramming. GFPþ colonies were quantiﬁed at day 11 post-transduction.
Fold induction and error bars were calculated from three independent experiments in triplicate wells. ***Po0.0001. (D) The enhancing effect
of miR-93 and miR-106b is observed using the OSK system. miRNA mimics were transfected as in 4F experiments. GFPþ colonies were
quantiﬁed on days 15–20. Error bars represent s.d. of three independent experiments in triplicate wells. ***Po0.0001. (E) miR-93 and miR-
106b inhibitors dramatically decrease reprogramming efﬁciency. miRNA inhibitors were transfected at a ﬁnal concentration of 50nM. The
experimental timeline was the same as in miR mimic transfections. Error bars represent s.d. of three independent experiments in triplicate
wells. ***Po0.0001. (F) miR-106b promotes the MET transition during 4F-mediated reprogramming. miR-106b mimic was transfected into
MEFs and cells were harvested at different time points to analyze E-Cadherin expression. Fold induction of ECad was normalized to day 4
samples after 4F infection. Error bars represent s.d. of three independent experiments. *Po0.001. (G) miR-106b promotes the MET transition in
OSK-infected cells. The experimental procedures were the same as in (F). Fold induction of ECad was normalized to day 4 samples after OSK
infection. Error bars represent s.d. of three independent experiments. *Po0.001. (H) Inhibition of miR-106b decreases induction of MET
process. The experimental procedures were the same as in (F), except anti-miRoligos were transfected instead of miR mimics. Fold induction of
ECad was normalized to day 4 samples after 4F infection. Error bars represent s.d. of three independent experiments. *Po0.001.
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To further understand the mechanism underlying miR-93
and miR-106b enhancement of reprogramming efﬁciency,
we investigated cellular targets of these miRNAs. We chose
miR-93 for analysis since it shares the same seed region as
miR-106b. miR-93 mimics were transfected into MEFs, and
total RNAs were harvested at day 2 for mRNA expression
proﬁle analysis (Supplementary Table 4). That analysis iden-
tiﬁed potential functional targets of miR-93 that we compared
with published expression proﬁles of MEFs and iPSCs
(Sridharan et al, 2009). We found that genes signiﬁcantly
decreased upon miR-93 transfection showed a 3-fold enrich-
ment of genes, which are lowly expressed in iPSCs
(Supplementary Figure S13a), while genes which were
increased upon miR-93 transfection did not show such en-
richment. In addition, we undertook pathway ontology ana-
lysis of the expression proﬁle of miR-93-transfected MEFs
(data not shown). Interestingly, two important pathways for
iPS induction were regulated by miR-93: TGF-b signaling and
G1/S transition pathways.
For TGF-b signaling, Tgfbr2 is among one of the most
signiﬁcantly decreased genes upon miR-93 transfection.
Tgfbr2 is a constitutively active receptor kinase that has a
critical role in TGF-b signaling, and recent small molecule
screens indicate that inhibitors of its heterodimeric partner
Tgfbr1 enhance iPSC induction (Ichida et al, 2009; Maherali
and Hochedlinger, 2009). miRNA target site prediction
suggested that there were two conserved targeting sites for
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endogenous ES markers. Total RNAs were isolated from iPS cell lines at day 3 post-passage. ES cell-speciﬁc markers such as ERas, ECatI, Nanog
and endogenous Oct4 expression were analysed by RT–PCR. (D) Cells from all three germ layers can be obtained in embryoid body (EB) assays
using derived iPS clones. iPS cells were cultured for EB formation at B4000cells/20ml drop for 3 days, and EBs were then reseeded onto
gelatin-coated plates for further culture until day 12–14, when beating cardiomyocytes were observed (Supplementary Video 1). Cells were
immunostained with different lineage markers: b-tubulin III, ectoderm marker; AFP, endoderm marker; a-actinin, mesoderm marker.
(E) Teratomas form from injected iPS cells. In total, 1.5 million cells were injected into each mouse, and tumours were harvested 3–4
weeks after injection for parafﬁn embedding and H&E staining. Structures representing different lineages are labeled. Representative pictures
are from miR-106b clone 1#. (F) Derived clones can be used to generate chimeric mice. iPS cells were injected into blastocysts from albino or
black C57B6 mice (NCI) and the contribution of iPSCs can be seen with agouti or black coat colour.
RNA-based iPSC reprogramming
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choose it as the candidate target for further investigation.
Regarding the G1/S transition, we choose p21 as the
potential target because recent results in human solid tumour
samples (breast, colon, kidney, gastric and lung) and gastric
cancer cell lines indicate that the miR-106bB25 cluster can
target cell cycle regulators, such as the CDK inhibitors p21
and p57 (Ivanovska et al, 2008; Kim et al, 2009b) and that
human and mouse p21 share a conserved miR-93/106b target
site in the 30UTR. Furthermore, mES cell-speciﬁc miRNA
clusters, such as miR-290 and miR-293, reportedly target
negative regulators of the G1/S transition, including p21
(Wang et al, 2008). miR-290 and miR-293 cluster miRNAs
also share very similar seed regions with miR-93 and miR-
106b (unpublished observations). p21 is also greatly induced
by OSKM factors during early stages of iPSC induction
(Kawamura et al, 2009), an upregulation that we conﬁrmed
in MEFs (Supplementary Figure S12a). Detailed analysis
revealed that p21 induction is primarily due to Klf4
and cMyc misexpression, as a combination of Oct4 and
Sox2 only did not signiﬁcantly alter p21 protein levels
(Supplementary Figure S12a).
To determine whether mouse Tgfbr2 and p21 are targeted
by miR-93 and miR-106b, miR mimics were transfected into
MEFs (Supplementary Table 5) and total cell lysates were
analysed by western blotting 48h later. Indeed, miR-93 and
miR-106b expression efﬁciently decreased both Tgfbr2 and
p21 protein levels (Figure 5A and D) and p21 mRNA levels
were decreased by B25–30% while Tgfbr2 was decreased by
B60–70% (Supplementary Figure S14a and b). These levels
of suppression were further conﬁrmed in 4Fand OSK-infected
MEFs (Supplementary Figures S15 and S16). To determine
whether p21 is a direct target of miR-93 and miR-106b, we
constructed a luciferase reporter with p21 30UTR sequence
inserted downstream of the ﬁreﬂy luciferase coding
sequence. We observed consistent B40% repression of luci-
ferase activity following transfection of miR-93 and miR-106b
mimics into co-transfected Hela cells, a repression lost when
mutations were introduced into the seed region of conserved
p21 30UTR target sites (Supplementary Figure S17a and b).
For Tgfbr2, luciferase assay also showed B50% decrease of
GL activity while miR-93 mutant did not have such effect
(Supplementary Figure S18a and b).
Cell cycle arrest promoted by p21 may inhibit epigenetic
modiﬁcations required for reprogramming, as those modiﬁ-
cations occur more readily in proliferating cells. To determine
whether p21 expression compromises iPS, HA-tagged p21
cDNA was cloned into the pMX retroviral backbone and
overexpressed in MEF cells. When HA-p21 virus was
introduced into MEFs together with the four OSKM factors,
an almost complete inhibition of iPS induction was observed,
based on both AP staining and Oct4-GFP-positive colony
formation (Supplementary Figure S19a). Similar results
were obtained when the three OSK factors were used for
reprogramming (Supplementary Figure S19b).
As our analysis indicated that miR-93 and miR-106b
efﬁciently repress both Tgfbr2 and p21 expression, we
asked whether Tgfbr2 and p21 activity antagonizes repro-
gramming. To do so, we transfected Tgfbr2 or p21 siRNAs
into MEFs using the same experimental timeline employed
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Figure 5 miR-93 and miR-106b directly target mouse p21 and Tgfbr2. (A) miR-93 and miR-106b transfection decreases p21 protein levels. Oct4-
GFP MEFs were transfected with 50nM miR mimics and harvested 48h after transfection for western analysis. Actin was used as the loading
control. (B) p21 is knocked down efﬁciently by siRNA. p21 siRNA- and control-transfected MEFs were harvested at 48h and RT–qPCR, and
western blotting was undertaken to verify p21 expression. p21 mRNAs were normalized to GAPDH. (C) Knock-down of p21 by siRNA enhances
iPSC induction. MEFs were infected with 4F virus, and siRNAs were transfected following the same timeline as miRNAs mimic transfection.
GFPþ colonies were quantiﬁed at day 11. Error bars represent three independent experiments in triplicate wells. (D) miR-93 and miR-106b
transfection decreases TGFBR2 expression. Transfected cells were harvested at 48h for western blotting. (E) Tgfbr2 is knocked down by
siRNAs. Relative Tgfbr2 mRNA levels were normalized to those of GAPDH. (F) Knock-down of Tgfbr2 by siRNAs enhances iPSC induction.
Error bars represent four independent experiments in triplicate wells.
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ﬁrmed that both protein and mRNA levels, respectively, were
efﬁciently knocked down by siRNAs without virus transduc-
tion (Figure 5B and E). MEF reprogramming was then in-
itiated by OSKM transduction, and Oct4-GFPþ colonies
were quantiﬁed at day 11 post-transduction. We observed a
B2-fold induction in colony number for each gene (Figure 5C
and F). TGF-b receptor II (TGFBR2) was also overexpressed in
MEFs, and iPS enhancement by miR-106b was compromised
under such condition (Supplementary Figure S20).
Altogether, our data identify that Tgfbr2 and p21 are the
direct target of miR-93 and miR-106b and down regulation of
these genes can enhance the reprogramming process.
Additional upregulated miRNAs enhance iPSC induction
As noted, we identiﬁed three miRNA clusters induced by
reprogramming factors, and several miRNAs within these
clusters have the same seed regions, suggesting that they
target similar mRNAs (Figure 2). To investigate whether other
miRNAs that share the same seed region with miR-93 and
miR-106b also enhance iPSC induction, miRNA mimics of
miR-17 and miR-106a were tested using an experimental
procedure similar to that described above for miR-93 mimic
treatment and iPSC induction. These miRNAs enhanced
reprogramming in a manner similar to that seen with the
miR-106bB25 clusters (Figure 6A), and transfection of these
miRs resulted in decreased TGFBR2 and p21 protein levels
(Figure 6B and C) as well as Tgfbr2 mRNA (Supplementary
Figure S21). Together, this evidence suggests that induction of
miR-17B92, miR-106bB25 and miR-106aB363 clusters is
important for proper reprogramming and that upregulation
of these miRNAs lowers reprogramming barriers to the iPSC
generation process (Figure 6D).
Discussion
Since the discovery that MEFs can be reprogrammed to iPSCs,
much effort has been directed toward understanding funda-
mental mechanisms underlying this process. Our results
show for the ﬁrst time that post-transcriptional gene regula-
tion occurs during reprogramming and that interference with
the RNAi machinery can signiﬁcantly alter reprogramming
efﬁciency. We identiﬁed three miRNAs clusters signiﬁcantly
upregulated by the four factors used to induce iPSCs and
found that miRNAs in those clusters likely target two im-
portant reprogramming pathways: TGF-b signaling and cell
cycle control. While these experiments were in progress,
several investigators also reported that the p53 pathway,
which includes downstream tumour suppressors such as
p21, is a major barrier to iPSC induction (Banito et al,
2009; Hong et al, 2009; Kawamura et al, 2009; Utikal et al,
2009; Li et al, 2009a). Much evidence indicates that ectopic
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Figure 6 Reprogramming is enhanced by other family miRNAs. (A) miR-17 and miR-106a can also enhance reprogramming efﬁciency. miR-17
and miR-106a mimics were transfected into MEFs at a ﬁnal concentration of 50nM. GFPþ colonies were quantiﬁed at day 11 post-transduction.
Error bars represent three independent experiments in triplicate wells. (B) miR-17 and miR-106a also target p21. p21 western blotting was
performed 2 days after transfection of miRNA mimics into MEFs. (C) miR-17 and miR-106a target TGFBR2 expression. miRNA mimics were
transfected into MEFs at 50nM ﬁnal concentration. Western blotting was performed 2 days post-transfection. (D) Model for the role for
miRNAs during iPS induction. Several miRNAs, including miR-17, miR-25 and miR-106a clusters, are induced during early stages of
reprogramming. These miRNAs facilitate full reprogramming by targeting factors that antagonize the process, such as p21 and other
unidentiﬁed proteins. Up and down represent the potential different stages and barriers during reprogramming process and dashed line
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and initiates cellular ‘defense programs’, such as cell cycle
arrest, apoptosis or DNA damage responses. These responses
likely underlie low reprogramming efﬁciency, which we
observe to be B0.1%. However, these data do not explain
how successfully reprogrammed cells overcome these bar-
riers to become iPSCs. Our data suggest that cells do so in
part by inducing expression of miRNAs that target pathways
that antagonize successful reprogramming. By modulating
miRNA levels in primary ﬁbroblasts, we were able to achieve
a signiﬁcant increase in reprogramming efﬁciency.
TGF-b signaling is an important pathway that functions in
processes as diverse as gastrulation, organ-speciﬁc morpho-
genesis and tissue homeostasis (Moustakas and Heldin,
2009). The current model of canonical TGF-b transduction
indicates that TGF-b ligand binds the TGFBR2, which then
heterodimerizes with TGF-b receptor I (TGFBR1) to transduce
signals through receptor-associated Smads (Kahlem and
Newfeld, 2009). TGF-b signaling reportedly functions in
both hES and mES cell self-renewal, and FGF2, a widely
used growth factor for ES cell culture, induces TGF-b ligand
expression and suppresses BMP-like activities (Greber et al,
2007; Ogawa et al, 2007). Blocking TGFBRI family kinases by
chemical inhibitors compromises ES cell self-renewal (Ogawa
et al, 2007). These ﬁndings are particularly signiﬁcant for
iPSC induction, because those inhibitors seem to have com-
pletely different roles during reprogramming. Recent chemi-
cal screening has shown that small molecules inhibitors of
the TGFBR1 actually enhance iPSC induction and can replace
the requirement for Sox2 by inducing Nanog expression
(Ichida et al, 2009). Moreover, treating reprogramming cells
with TGF-b ligands has a negative effect on iPSC induction
(Maherali and Hochedlinger, 2009). Therefore, although
TGF-b signaling is important for ES cell self-renewal, it is a
barrier for reprogramming. Our results determined that, in
addition to TGFBR1, activity of the constitutively active
kinase TGFBR2 also antagonizes reprogramming. Here, for
the ﬁrst time, we demonstrate that miR-93 and its family
members directly target TGFBR2 to modulate its’ signaling
and reprogramming.
p21, a protein of only 165 amino acids, functions as a
tumour suppressor by mediating p53-dependent G1 growth
arrest and promoting differentiation and cellular senescence
(Abbas and Dutta, 2009). Our data (Supplementary Figure
S11) and that of others (Kawamura et al, 2009) demonstrate
that p21 expression is upregulated when the four factors
(OSKM) are introduced into MEFs and that this upregulation
antagonizes reprogramming, as p21 overexpression almost
completely blocked iPSC induction (Supplementary Figure
S16). p21 induction in reprogramming cells could be depen-
dent or independent of p53, as the Klf4 reprogramming factor
reportedly binds to the p21 promoter and increases p21
transcription (Abbas and Dutta, 2009). This ﬁnding raises
an interesting question regarding the function of the four
reprogramming factors, as the same transcription factor can
both promote and antagonize iPSC induction. In fact, we
cannot currently rule out the possibility that a certain level of
p21 induction beneﬁts the reprogramming process. Besides
its well-known role in p53-dependent cell cycle arrest, p21
also reportedly has an oncogenic activity by protecting cells
from apoptosis, a function unrelated to its usual role in cell
cycle control (Abbas and Dutta, 2009). A potential beneﬁt for
p21 in reprogramming may depend on its ability to regulate
gene expression through protein–protein interactions (Abbas
and Dutta, 2009). For example, p21 directly binds to several
proteins regulating apoptosis, such as caspases 8 and 10 and
procaspase 3. It also suppresses pro-apoptotic activity of Myc
by associating with the Myc N-terminus to block Myc-Max
heterodimerization (Abbas and Dutta, 2009). Indeed, when
Myc itself is overexpressed in MEFs, a signiﬁcant increase in
cell death is observed in cell culture, while in four-factor
transduced cells, cell death is minimal compared with Myc-
only samples (data not shown). Therefore, p21 induction may
not only serve as a barrier to reprogramming but may
maintain levels of p21 necessary to reduce apoptosis and
thus increase reprogramming efﬁciency. Our data serve as
partial evidence to support this hypothesis, as miR-93 and
miR-106b treatment had greater enhancing effects on repro-
gramming than did p21 siRNA transfection (Figures 3C, 5A
and C). It is also possible that this effect is due to targeting of
multiple proteins such as TGFBR2 in addition to p21 by these
miRNAs.
Finally, as the miR clusters identiﬁed here, such as miR-
17B92, miR-106bB25 and miR-106aB363, are induced
during iPS induction and are conserved between mouse and
humans, the enhancing effects of miR-93 and miR-106b may
apply to human reprogramming. Further studies should focus
on the activity of these miRNAs in human cells and in various
disease models.
Materials and methods
Cell culture, vectors and virus transduction
Oct4-GFP MEFs were derived from mice carrying an IRES–EGFP
fusion cassette downstream of the stop codon of pou5f1 (Jackson
Lab, Stock#008214) at E13.5. MEFs were cultured in DMEM
(Invitrogen, 11995-065) with 10% FBS (Invitrogen) plus glutamine
and NEAA. Only MEFs at passage of 0–4 were used for iPS
induction. pMX-Oct4, Sox2, Klf4 and cMyc were purchased from
Addgene. pMX-HA-p21 was generated by inserting N-terminally
tagged-p21 into the pMX EcoRI site. pLKO-shRNA clones were
purchased from Open Biosystems. To generate retrovirus, PLAT-E
cells were seeded in 10cm plates, and 9mg of each factor was
transfected the next day using Lipofectamine (Invitrogen, 18324-
012) and PLUS (Invitrogen, 11514-015). Viruses were harvested and
combined 2 days later. For iPS induction, MEFs were seeded in 12-
well plates and transduced with ‘four factor’ virus the next day with
4mg/ml polybrene. One day later, the medium was changed to fresh
MEF medium, and 3 days later it was changed to mES culture
medium supplemented with LIF (Millipore, ESG1107). GFPþ
colonies were picked at day 14 post-transduction, and expanded
clones were cultured in DMEM with 15% FBS (Hyclone) plus LIF,
thioglycerol, glutamine and NEAA. Irradiated CF1 MEFs served as
feeder layers to culture mES cells and derived iPS clones. To
generate shRNA lentivirus, shRNA lentiviral vectors were co-
transfected into 293FTcells together with the pPACK-H1 packaging
system (SBI, LV500A-1). Lentiviruses were harvested at day 2 after
transfection and centrifuged at 4000r.p.m. for 5min at room
temperature. shRNAvirus was added together with four factor virus
at a volume ratio of 1:1:1:1:1.
miRNA and siRNA transfection of MEFs
miRNA mimics and inhibitory siRNAs were purchased from
Dharmacon. To transfect MEFs, miRNA mimics or inhibitors were
diluted in Opti-MEM (Invitrogen, 11058-021) to the desired ﬁnal
concentration. Lipofectamine 2000 (Invitrogen, 11668-019) was
added to the mix at 2ml/well in 12-well plates, which were
incubated for 20min at room temperature. For 12-well transfec-
tions, 80ml of the miR mixture was added to each well with 320mlo f
Opti-MEM. Three hours later, 0.8ml of the virus mixture (for iPS) or
RNA-based iPSC reprogramming
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to fresh MEF medium the next day.
Western blotting
Total cell lysates were prepared by incubating cells in MPER buffer
(PIERCE, 78503) on ice for 20min, and then cleared by centrifuga-
tion at 13000r.p.m. for 10min. An equal volume of lysates was
loaded onto 10% SDS–PAGE gels, and proteins were transferred
onto PVDF membranes (Bio-Rad, 1620177) using the semi-dry
system (Bio-Rad). Membranes were blocked with 5% milk in TBST
for at least 1h at room temperature or overnight at 41C. Antibodies
used include anti-p21 (BD, 556430), anti-mNanog (R&D, AF2729),
anti-h/mSSEA1 (R&D, MAB2156), anti-HA (Roche, 11867423001),
anti-mAgo2 (Wako, 01422023), anti-Dicer (Abcam, ab13502), anti-
Drosha (Abcam, ab12286), anti-Actin (Thermo, MS1295P0), anti-
AFP (Abcam, ab7751), anti-b III tubulin (R&D systems, MAB1368),
anti-TGBR2 (Cell signaling, 3713s) and anti-a actinin (Sigma,
A7811).
mRNA and miRNA qPCR
Total RNAs were extracted using Trizol (Invitrogen). After extrac-
tion, 1mg total RNA was used for RT using Superscript II
(Invitrogen). qPCR was performed using a Roche LightCycler480
II and the Sybr green mixture from Abgene (Ab-4166). Mouse Ago2,
Dicer, Drosha, Gapdh and p21 primers are listed in Supplementary
Table 2. Other primers were previously described (Takahashi and
Yamanaka, 2006). For miRNA quantitative analysis, total RNA was
extracted using the method above. After extraction, 1.5–3mg of total
RNA was used for miRNA reverse transcription using QuantiMir kit
following the manufacturer’s protocol (SBI, RA420A-1). RT pro-
ducts then were used for qPCR using the mature miRNA sequence
as a forward primer together with the universal primer provided
with the kit.
Immunostaining
Cells were washed twice with PBS and ﬁxed with 4% paraformal-
dehyde at room temperature for 20min. Fixed cells were
permeabilized with 0.1% Triton X-100 for 5min. Cells were then
blocked in 5% BSA in PBS containing 0.1% Triton X-100 for 1h at
room temperature. Primary antibody was diluted from 1:100 to
1:400 in 2.5% BSA PBS containing 0.1% Triton X-100, according to
the manufacturer’s suggestion. Cells were stained with primary
antibody for 1h and then washed three times with PBS. Secondary
antibody was diluted 1:400 and cells were stained for 45min at
room temperature.
EB formation and differentiation assay
iPSCs were trypsinized into a single cell suspension and the hanging
drop method was used to generate EBs. For each drop, 4000 iPSCs
in 20ml EB differentiation medium were used. EBs were cultured in
hanging drops for 3 days before being reseeded onto gelatin-coated
plates. After reseeding, cells were further cultured until day 14
when beating areas could be identiﬁed.
Promoter methylation analysis
CpG methylation of the Nanog and Pou5f1 promoters was analysed
following procedures described elsewhere (Takahashi and Yamana-
ka, 2006). Brieﬂy, genomic DNA of derived clones was extracted
using a Qiagen kit. In total, 1mg DNA was then used for genome
modiﬁcation analysis following the manufacturer’s protocol (EZ
DNA Methylation—Direct Kit, Zymo Research, D5020). After
modiﬁcation, PCR of selected regions was performed, and the
products were cloned into pCR2.1-TOPO (Invitrogen). Ten clones
were sequenced for each gene.
Teratoma formation and chimera generation
To generate teratomas, iPSCs were trypsinized and resuspended at a
concentration of 1 10
7cells/ml. Athymus nude mice were ﬁrst
anesthetized with Avertin, and then B150ml of the cell suspension
was injected into each mouse. Mice were checked for tumours every
week for 3–4 weeks. Tumours were harvested and ﬁxed in zinc
formalin solution for 24h at room temperature before parafﬁn
embedding and H&E staining. To test the capacity of derived
iPSC clones to contribute to chimeras, iPSCs were injected into
C57BL/6J-Tyr
(C 2J)/J (albino) blastocysts. Generally, each blastocyst
received 12–18 iPSCs. ICR recipient females were used for embryo
transfer. The donor iPSC cells are in either agouti or black colour.
mRNA microarray analysis
miR-93 and siControl were transfected into MEFs and total RNAs
were harvested at 48h post-transfection. mRNA microarray was
carried out by Microarray facility in Sanford-Burnham Institute.
Gene lists for both potential functional targets (fold change 42,
Po0.05) and total targets (fold change 425%, Po0.05) were
generated by ﬁltering through volcano maps. Gene lists were then
used for ontology analysis using GeneGo software following
guidelines from the company.
Dual luciferase assay
30UTR of both p21 and Tgfbr2 were cloned into XbaI site of pGL3
control vectors. For each well of 12-well plates, 200ng of resulted
vectors and 50ng of pRL-TK (renilla luciferase) were transfected
into 1 10
5 Hela cells which were seeded 1 day before the
transfection. In total, 50nM of miRNAs were used for each
treatment and cell lysates were harvested at day 2 post-transfection.
In total, 20ml of lysates were then used for dual luciferase assay
following the manufacturer’s protocol (Dual-Luciferase
s Reporter
Assay System Promega, E1910).
Cell proliferation assay
In total, 3000 MEFs were seeded in each well in 96-well plates and
transduced with 4F virus and shRNA lentivirus (or transfected with
miRNA inhibitors). Starting from day 1 post-transduction/transfec-
tion, every 2 days, cells were incubated with mES medium
containing Celltiter 96 Aqueous one solution (Promega, G3580)
for 1h in tissue culture incubator. Absorbance at 490nm was then
measured for each well using plate reader and collected data were
used to generate relative proliferation curve using signal from day 1
post-transduction/transfection as the reference.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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